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ABSTRACT
Genome-wide association studies (GWAS) have detected
association between variants in or near the Lysophospholipase-like
1 (LYPLAL1) locus and metabolic traits, including central obesity,
fatty liver and waist-to-hip ratio. LYPLAL1 is also known to
be upregulated in the adipose tissue of obese patients. However,
the physiological role of LYPLAL1 is not understood. To investigate
the function of Lyplal1 in vivo we investigated the phenotype of the
Lyplal1tm1a(KOMP)Wtsi homozygous mouse. Body composition was
unaltered in Lyplal1 knockout mice as assessed by dual-energy
X-ray absorptiometry (DEXA) scanning, both on normal chow and on
a high-fat diet. Adipose tissue distribution between visceral and
subcutaneous fat depots was unaltered, with no change in adipocyte
cell size. The response to both insulin and glucose dosingwas normal
in Lyplal1tm1a(KOMP)Wtsi homozygous mice, with normal fasting blood
glucose concentrations. RNAseq analysis of liver, muscle and
adipose tissue confirmed that Lyplal1 expression was ablated with
minimal additional changes in gene expression. These results
suggest that Lyplal1 is dispensable for normal mouse metabolic
physiology and that despite having been maintained through
evolution Lyplal1 is not an essential gene, suggesting possible
functional redundancy. Further studies will be required to clarify its
physiological role.
KEY WORDS: Adipose tissue, Genome-wide association study,
Lyplal1, Model organism, Mouse, Obesity
INTRODUCTION
Lysophospholipase-like 1 (LYPLAL1) is a protein with a poorly
understood biological role, despite its evolutionary conservation
(Fig. S1). The crystal structure of LYPLAL1 is similar to that ofAPT1
(acyl protein thioesterase 1, also known as LYPLA1), but the shape of
its active site indicates that unlike APT1, which depalmitoylates Gα
and Ras proteins, it cannot bind long-chain substrates. Biochemical
data confirm this, also demonstrating that LYPLAL1 accepts short-
chain 4-nitrophenyl esters (Bürger et al., 2012). Despite identification
of a small-molecule inhibitor, the natural substrate of LYPLAL1 and
its physiological role remain unknown.
Genome-wide association studies (GWAS) have identified
variants close to LYPLAL1 associated with various metabolic-
related phenotypes, including waist-to-hip ratio, with a greater effect
in females (Heid et al., 2010; Lindgren et al., 2009; Randall et al.,
2013), subcutaneous-to-visceral white adipose tissue (scWAT/
vWAT) ratio (Chu et al., 2017; Fox et al., 2012), body mass index
(Benjamin et al., 2011), fasting insulin concentration, insulin
resistance (Bille et al., 2011; Manning et al., 2012; Scott et al.,
2012), insulin clearance (Goodarzi et al., 2013), increased fasting
serum triglyceride concentration in males (Bille et al., 2011) and
non-alcoholic fatty liver disease (Speliotes et al., 2011). In addition,
the rs8486567 single nucleotide polymorphism (SNP) downstream
of LYPLAL1 was included in a genetic risk score associated with
excess body mass loss after Roux-en-Y gastric bypass surgery
(Bandstein et al., 2016).
Lyplal1 is broadly expressed in the mouse, with higher expression
in white adipose tissue (WAT), liver, skeletal muscle and kidney.
Lyplal1 expression was downregulated in a depot-specific manner
in mice on a high-fat diet (HFD) (Lei et al., 2015). Likewise,
Lyplal1 expression was lower in kidney fat of Zucker diabetic fatty
rats, compared with Zucker lean rats (Schmid et al., 2012), yet
LYPLAL1 expression is increased in WAT from obese patients
(Steinberg et al., 2007) and in the liver in mouse metabolic disease
models (Ahn et al., 2016).
Selective inhibition of LYPLAL1 in cultured hepatocytes caused
an increase in glucose production (Ahn et al., 2016), and adipocyte
studies indicate that Lyplal1 is not required for adipocyte
differentiation (Lei et al., 2015).
Given previous human GWAS results, and the pathophysiological
alteration in gene expression levels, we hypothesized that LYPLAL1
is important for metabolic regulation. We characterized a Lyplal1
knockout mouse model, aiming to elucidate the function of
Lyplal1 in vivo and to establish whether LYPLAL1 is a plausible
causal gene at this locus.
RESULTS
Verification of Lyplal1 knockout
Mice with loss of Lyplal1 (termed Lyplal1tm1a/tm1a) were generated
using the tm1a knockout first allele design as part of the
International Mouse Phenotyping Consortium (IMPC) project
(Fig. 1A). Lyplal1 mRNA levels were negligible in all organs
tested, with the tm1a allele resulting in >95% knockout of Lyplal1 at
the RNA level in the kidney and gastrocnemius muscle, and >99%
knockout in all other tissues tested (heart, liver, spleen and adipose
tissue; Fig. 1B-I). Furthermore, RNAseq confirmed loss of Lyplal1
expression, consistent with the gene construct, with only a few
detectable reads mapping to exon 1 (Fig. S2). No other exons
display complete coverage in any of the Lyplal1tm1a/tm1a samples
investigated, with no more than three reads at any one base outside
exon 1. The reduction in reads for exon 1 might be attributable to
disruption of an unmapped regulatory element, such as an enhancer
in the first exon, or a result of nonsense-mediated decay. The alleleReceived 31 August 2017; Accepted 17 October 2017
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design is such that transcription is prevented beyond the lacZ in the
inserted cassette. However, in the case of any skipped splicing over
the cassette, the resulting transcripts would be frameshifted and
subject to nonsense-mediated decay. It might also be possible that
the Exon1∷LacZ transcript is detected as aberrant and degraded.
Lyplal1 was undetectable in all protein samples collected from
homozygous Lyplal1tm1a/tm1a mice (Fig. 1J; Fig. S3).
Body composition
No obvious body weight or metabolic phenotype was observed
for Lyplal1tm1a/tm1a mice during standardized phenotyping (www.
mousephenotype.org/data/genes/MGI:2385115) (White et al., 2013).
To investigate further the role of Lyplal1 on adipose tissue
development, and other relevant metabolic phenotypes, mice were
challenged with a HFD from 6 weeks of age. Body weight and nose-
to-tailbase length were not altered in HFD-fed Lyplal1tm1a/tm1a mice,
compared with wild type (Fig. 2A; Fig. S4A,B). Lean and fat mass
composition and bone mineral parameters were also unaltered in
Lyplal1tm1a/tm1amiceat 14and24 weeksof age (Fig. 2B-D;Fig.S4C-K).
To investigate fat distribution, vWAT, scWAT and brown adipose
tissuewere dissected from28-week-oldmice andweighed.No change
was detected in Lyplal1tm1a/tm1a mice (Fig. 2E-G), indicating that
Fig. 1. Mice were generated with the Lyplal1tm1a allele, resulting in knockout at both the protein and the RNA level. (A) Diagram showing the Lyplal1tm1a
allele design (figure obtained from IMPC, www.mousephenotype.org/data/genes/MGI:2385115). RNA and protein were extracted from organs from 28-week-old
mice. (B-I) qPCR analysis of Lyplal1 mRNA levels in gastrocnemius (B), heart (C), liver (D), kidney (E), spleen (F), BAT (G), scWAT (H) and vWAT (I).
Data are presented as means±s.d. Black triangles, male Lyplal1+/+; white triangles, male Lyplal1tm1a/tm1a; black circles, female Lyplal1+/+; white circles, female
Lyplal1tm1a/tm1a. (J) Protein levels of Lyplal1 and GAPDH were determined by Western blot in liver, kidney, scWAT and vWAT lysates. Representative blots
are shown. [(B) n=5 female Lyplal1tm1a/tm1a, n=7 other groups; (C,E-G) n=3 each group; (D) n=7 Lyplal1+/+, n=8 Lyplal1tm1a/tm1a; (H) n=8 male Lyplal1+/+,
n=6 male Lyplal1 tm1a/tm1a, n=5 female Lyplal1+/+, n=5 female Lyplal1tm1a/tm1a; (I) n=5 male Lyplal1+/+, n=3 male Lyplal1tm1a/tm1a, n=5 female Lyplal1+/+, n=6
female Lyplal1tm1a/tm1a; (J) n=3 samples from each sex and genotype per tissue]. KO, knockout; scWAT, subcutaneous white adipose tissue; vWAT, visceral white
adipose tissue; WT, wild type.
1482
RESEARCH ARTICLE Disease Models & Mechanisms (2017) 10, 1481-1488 doi:10.1242/dmm.031864
D
is
ea
se
M
o
d
el
s
&
M
ec
h
an
is
m
s
Lyplal1 is dispensable for adipose tissue distribution and size in mice.
All other organ weights measured (liver, kidney, gastrocnemius and
tibialis anterior muscles, heart and spleen) were similar towild type in
Lyplal1tm1a/tm1a mice at 28 weeks of age (Table S1).
To determine whether adipose tissue architecture was altered,
adipocyte cross-sectional area (CSA) was determined from
scWAT sections (Fig. 2H-I). No changes were observed, either
in average adipocyte CSA (Fig. 2I) or in the distribution of cell
Fig. 2. Lyplal1 knockout does not alter body composition in Lyplal1 knockout mice fed high-fat diet from 6 weeks of age. (A) Body weights of mice
up to 28 weeks of age were not altered by genotype. (B-D) Lean mass (B), fat mass (C) and fat percentage (D) were unaltered in 24-week-old mice, measured by
DEXA. (E-G) scWAT (E), vWAT (F) and BAT (G) mass were unchanged in 28-week-old mice, weighed after dissection. (H) No qualitative change in scWAT
morphology in knockout mice. Representative images are shown of scWAT sections from 28-week-old mice stained with H&E. (I) No change in adipocyte CSA
was determined using ImageJ analysis of scWAT sections stained with H&E, analysed using PhenStat. (J) No change in fatty liver in knockout mice.
Representative images are shown of liver sections from 28-week-old mice stained with Oil Red O and Haematoxylin. Black triangles, male Lyplal1+/+; white
triangles, male Lyplal1tm1a/tm1a; black circles, female Lyplal1+/+; white circles, female Lyplal1tm1a/tm1a. Data are presented as means±s.d. Mixed model analysis
was performed using PhenStat. [(B-D) n=10 male Lyplal1+/+, n=11 male Lyplal1tm1a/tm1a, n=9 female Lyplal1+/+, n=8 female Lyplal1tm1a/tm1a; (E,F) n=9 male
Lyplal1+/+, n=10 male Lyplal1tm1a/tm1a, n=9 female Lyplal1+/+, n=7 female Lyplal1tm1a/tm1a; (G) n=10 male Lyplal1+/+, n=10 male Lyplal1tm1a/tm1a, n=9 female
Lyplal1+/+, n=8 female Lyplal1tm1a/tm1a; (H,I) n=9 male Lyplal1+/+, n=8 male Lyplal1tm1a/tm1a, n=7 female Lyplal1+/+, n=8 female Lyplal1tm1a/tm1a]. BAT, brown
adipose tissue; CSA, cross-sectional area; H&E, Haemotoxylin and Eosin; KO, knockout; scWAT, subcutaneous white adipose tissue; vWAT, visceral white
adipose tissue; WT, wild type.
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CSA (Fig. S5). Furthermore, liver cryosections showed no
qualitative differences in Lyplal1tm1a/tm1a mice compared with
wild type (Fig. 2J), indicating that knockout of Lyplal1 does not
alter adipocyte size or the extent of fatty liver in adult mice on
a HFD.
Concentrations of plasma lipids (cholesterol, high-density
lipoprotein, low-density lipoprotein, non-esterified fatty acids and
triglycerides) and other metabolically relevant parameters (albumin,
alkaline phosphatase, alanine transaminase, amylase, aspartate
aminotransferase, creatine kinase, creatinine, fructosamine and
glycerol) were determined in 28-week-old mice after a 4 h fast
(Table 1). No parameters were altered in Lyplal1tm1a/tm1a mice
compared with wild type, again suggesting that Lyplal1 does not
influence the regulation of these parameters.
Glucose homeostasis
Owing to potential links with fasting insulin concentration, insulin
clearance and insulin resistance, we investigated glucose
homeostasis in Lyplal1tm1a/tm1a mice. Fasting blood glucose was
measured at three ages after varying durations of fast. Although
concentrations differed according to sex, Lyplal1 knockout did not
alter fasting blood glucose in any conditions tested (Fig. S6). The
responses to insulin and glucose doses were tested via
intraperitoneal insulin and glucose tolerance tests at 18 and
22 weeks of age, respectively. Lyplal1tm1a/tm1a mice did not show
an altered response to either challenge (Fig. 3A-D). Plasma insulin
concentrations in 28-week-old Lyplal1tm1a/tm1a mice after a 4 h fast
were also unaltered (Fig. 3E). Collectively, these results indicate that
loss of Lyplal1 does not profoundly alter glucose homeostasis.
Indirect calorimetry
Indirect calorimetry was performed on 26-week-old mice for 48 h,
to collect data on food intake, energy expenditure and activity
levels. Activity levels and food intake during calorimetry were
normal in Lyplal1tm1a/tm1a animals (Fig. 3F; Fig. S7A,B,G,H).
Although there was a small significant difference in O2 uptake in
Lyplal1tm1a/tm1a mice, the energy expenditure, CO2 output
and respiratory exchange ratio remained unaltered, and traces
through the time period were all qualitatively similar (Fig. 3G,H;
Fig. S7C-F,J). Overall, the calorimetry did not demonstrate major
changes in energy homeostasis attributable to Lyplal1 loss.
RNAseq
As no phenotype alterations were observed in Lyplal1tm1a/tm1a mice,
we sought to investigate whether there were compensatory changes
in gene expression that might explain the apparent redundancy in
Lyplal1 function. We performed differential gene expression
analysis of RNAseq data obtained from metabolically relevant
tissues [liver, skeletal muscle (gastrocnemius), scWAT and vWAT].
As expected, Lyplal1 was the top differentially expressed gene
between knockout and wild type for all tissues, with additional
differentially expressed genes (P<0.05, adjusted for multiple
testing) listed in Table 2. Lyplal1 was the only differentially
regulated gene in gastrocnemius muscle, with only one additional
gene differentially regulated in liver (Nuak1), three additional genes
in scWAT and 11 additional genes in vWAT. Despite meeting the
significance threshold, all these additional genes have low log-fold
changes (0.2-0.75), indicating that knockout of Lyplal1 does not
cause substantial changes in the transcriptome in mice.
DISCUSSION
LYPLAL1 has been linked to many metabolic phenotypes in humans
and rodents, through GWAS and expression studies (Bandstein et al.,
2016; Benjamin et al., 2011; Bille et al., 2011; Chu et al., 2017; Fox
et al., 2012; Goodarzi et al., 2013; Heid et al., 2010; Lei et al., 2015;
Lindgren et al., 2009; Manning et al., 2012; Randall et al., 2013;
Schmid et al., 2012; Scott et al., 2012; Speliotes et al., 2011; Steinberg
et al., 2007). However, these results are correlative and do not
demonstrate direct causality of LYPLAL1 on associated phenotypes.
We therefore aimed to investigate the in vivo role of Lyplal1 in
metabolic regulation and adipose tissue deposition. We studied
Lyplal1tm1a/tm1a mice obtained from the Knockout Mouse Project
(KOMP) repository, with primary phenotyping obtained by the
Sanger Institute Mouse Genetics Project (MGP) (White et al., 2013).
In our hands, Lyplal1tm1a/tm1a mice did not display a detectable
metabolic phenotype, even under a HFD challenge. Loss of Lyplal1
expression was confirmed at both the RNA and the protein level,
with RNAseq data showing few detectable reads mapping to exon 1,
consistent with the gene construct. This suggests that the lack of
obvious phenotype was not attributable to residual Lyplal1
expression. In the absence of a detectable phenotype, there was
the possibility that another gene was compensating for Lyplal1.
However, our RNAseq data demonstrate minimal expression
Table 1. Concentrations of the listed parameters in plasma collected from 28-week-old knockout mice
Parameter
Male Female
Lyplal1+/+ Lyplal1tm1a/tm1a Lyplal1+/+ Lyplal1tm1a/tm1a
Albumin (g l−1) 27.07±1.575 26.89±1.508 28.26±0.974 28.26±0.974
ALP (U l−1) 81.60±16.61 88.79±22.67 96.50±19.31 99.78±14.95
ALT (U l−1) 213.9±103.7 223.6±110.6 111.9±45.9 115.5±43.57
Amylase (U l−1) 571.8±44.44 577.4±62.48 505.1±43.09 519.4±45.16
AST (U l−1) 218.9±67.96 202.1±88.21 171.8±27.64 164.7±50.08
Cholesterol (mmol l−1) 5.411±0.861 5.404±0.823 3.932±0.516 3.816±0.520
CK (U l−1) 359.1±162.8 290.1±194.0 361.6±228.7 252.0±234.7
Creatinine (µmol l−1) 8.911±1.040 7.878±1.353 9.578±0.821 9.629±1.805
Fructosamine (µmol l−1) 193.9±8.385 189.3±7.424 197.3±6.907 196.9±9.395
Glycerol (µmol l−1) 199.4±28.32 204.7±32.66 277.5±58.06 293.2±75.34
HDL (mmol l−1) 3.449±0.392 3.416±0.396 2.662±0.241 2.583±0.336
LDL (mmol l−1) 1.122±0.288 1.130±0.224 0.732±0.106 0.695±0.099
NEFAC (mmol l−1) 0.502±0.080 0.576±0.121 0.570±0.103 0.684±0.190
Triglycerides (mmol l−1) 0.444±0.065 0.476±0.076 0.458±0.067 0.493±0.118
Blood was collected retro-orbitally after a 4 h fast and plasma analysed using an Olympus AU400. ALP, alkaline phosphatase; ALT, alanine transaminase; AST,
aspartate aminotransferase; CK, creatine kinase; HDL, high-density lipoprotein; LDL, low-density lipoprotein; NEFAC, non-esterified fatty acids (n=9 male
Lyplal1+/+, n=9 male Lyplal1tm1a/tm1a, n=9 female Lyplal1+/+ and n=7 female Lyplal1tm1a/tm1a).
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changes in Lyplal1tm1a/tm1a mice, with small alterations in genes
unrelated to metabolism, suggesting that Lyplal1 is dispensable for
normal fat deposition and metabolic control in mice, despite its
evolutionary conservation.
Although the evidence implicating the LYPLAL1 locus in
regulation of fat distribution and metabolism was compelling, it is
important to remember that the SNPs identified by GWAS are not
within LYPLAL1 itself, and the underlying causal gene or effector
Fig. 3. Lyplal1 knockout does not alter glucose metabolism in mice. (A-D) Intraperitoneal insulin tolerance test (ipITT) at 18 weeks of age (A) and
intraperitoneal glucose tolerance test (ipGTT) at 22 weeks of age (B) demonstrated no alteration in glucose clearance in knockout mice. (C,D) The AUC was
calculated for both ipITT (C) and ipGTT (D). AUC mixed model analysis was performed using Phenstat. (E) Plasma insulin concentrations after a 4 h fast were
unaltered in 28-week-old knockout mice, determined by ELISA, mixedmodel analysis performed using PhenStat. (F-H) Indirect calorimetry of mice at 26 weeks of
age. No differences were observed in average activity count (F), RER (G) or energy expenditure (H). Black triangles, male Lyplal1+/+; white triangles, male
Lyplal1tm1a/tm1a; black circles, female Lyplal1+/+; white circles, female Lyplal1tm1a/tm1a; dashed line, male Lyplal1+/+; dotted line, male Lyplal1 tm1a/tm1a; dash-dot
line, female Lyplal1+/+; dash-dot-dot line, female Lyplal1tm1a/tm1a. Data are presented as means±s.d., with linear regression lines as appropriate. [(A,C) n=6 male
Lyplal1+/+, n=6 male Lyplal1tm1a/tm1a, n=6 female Lyplal1+/+, n=5 female Lyplal1tm1a/tm1a; (B,D) n=9 male Lyplal1+/+, n=9 male Lyplal1 tm1a/tm1a, n=10 female
Lyplal1+/+, n=8 female Lyplal1tm1a/tm1a; (E) n=10 male Lyplal1+/+, n=11 male Lyplal1tm1a/tm1a, n=9 female Lyplal1+/+, n=8 female Lyplal1tm1a/tm1a; (F,G) n=9
male Lyplal1+/+, n=8 male Lyplal1tm1a/tm1a, n=6 female Lyplal1+/+, n=7 female Lyplal1tm1a/tm1a; (H) n=9 male Lyplal1+/+, n=8 male Lyplal1 tm1a/tm1a, n=6 female
Lyplal1+/+, n=6 female Lyplal1tm1a/tm1a]. AUC, area under the curve; KO, knockout; RER, respiratory exchange ratio; WT, wild type.
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transcript has yet to be identified. It is therefore highly plausible that
these phenotypes are regulated via other genes. This has also been
well documented in the case of the identification of the causal gene
around the FTO locus (Church et al., 2009; Claussnitzer et al., 2015;
McMurray et al., 2013; Smemo et al., 2014; Stratigopoulos et al.,
2014), and reinforces the caution that must be taken when
interpreting GWAS results. Further studies, focused on fine-
mapping the LYPLAL1 locus and establishing a link between
associated genetic variants and effects on expression and regulation
of neighbouring genes, are therefore warranted to elucidate the
mechanisms through which these SNPs are acting. Indeed, similar
to most other GWAS loci, this variant maps to a non-coding region
that might be involved in modulating gene expression rather than
eliminating gene function. Therefore, modulating expression of
LYPLAL1, and other nearby genes, in different cells, tissues and
developmental stages might be required to inform the likely effector
transcript at this locus and fully test whether changes in Lyplal1
expression might contribute to the phenotype.
In conclusion, Lyplal1 is dispensable for normal adipose and
metabolic regulation in these mice for all parameters and conditions
tested here. Although there are differences between mice and
humans, and between mouse strains, this has important implications
for the interpretation of GWAS results linking SNPs close to
LYPLAL1 to metabolic phenotypes and highlights the challenges in
establishing causality based on GWAS results.
MATERIALS AND METHODS
Animal studies
All experiments were carried out in accordance with UK Home Office
regulations, UK Animals (Scientific Procedures) Act 1986, and with
approval from the Wellcome Trust Sanger Institute’s Animal Welfare
Committee. All mice were maintained in specific pathogen-free facilities in
individually ventilated cages at standard temperature (19-23°C) and
humidity (55±10%), on a 12 h dark, 12 h light (07.30-19.30 h) cycle.
Sperm from C57BL6/N mice carrying the targeted, non-conditional
allele Lyplal1tm1a(KOMP)Wtsi were obtained from the KOMP repository
(http://www.komp.org/pdf.php?projectID=23342; see allele design in
Fig. 1A) (Skarnes et al., 2011). Following confirmation of germ-line
transmission, mice derived from heterozygous intercrosses were genotyped
for the Lyplal1tm1a allele by PCR carried out as previously described (Ryder
et al., 2013).
Mice underwent standardized phenotyping using a modified version of
the Sanger Mouse Genetics Project pipeline detailed previously (White
et al., 2013), using breeder’s chow (LabDiets 5021, 21% kcal as fat;
LabDiet, London, UK) instead of a HFD. Lyplal1 data from the MGP
pipeline and others is available online: http://www.mousephenotype.org/
data/genes/MGI:2385115.
HFD studies using Research diets D12451 (45% kcal as fat; Research
Diets, New Brunswick, NJ, USA) were performed in three batches, with 11
males and 10 females of each genotype switched from breeder’s chow toHFD
at 6 weeks of age. Genotypes and sexes were mixed throughout the batches.
Body composition was measured under anaesthesia with ketamine
(Ketaset®; Fort Dodge Animal Health, Overland Park, KS, USA) and
xylazine (Rompun®; Bayer Animal Health, Leverkusen, Germany) using a
PIXImus densitometer (GE Lunar, Madison, WI, USA). Nose-to-tailbase
length was measured using a ruler with 1 mm graduations prior to dual-
energy X-ray absorptiometry (DEXA). This was performed at 12
(100 mg kg−1 ketamine and 10 mg kg−1 xylazine) and 22 weeks of age
(90 mg kg−1 ketamine and 9 mg kg−1 xylazine). Quality control was
performed using a calibrated phantom before imaging. Anaesthesia was
reversed by intraperitoneal injection of atipamezole (1 mg kg−1 Antisedan;
Orion Pharma, Espoo, Finland).
An intraperitoneal insulin tolerance test was performed on 16-week-old
mice after a 6 h fast (08.00-14.00 h), using 0.6 U kg−1 Actrapid insulin
(Novo Nordisk, Bagsvaerd, Denmark). An intraperitoneal glucose tolerance
test was performed on 20-week-old mice after an overnight fast (from
17.00 h, typically 16 h duration), using 2 g kg−1 glucose. Mice were
individually housed, and ∼0.5 mm of the tail tip was removed with a scalpel
blade and a fasting blood sample directly taken (Accu-chek Aviva; Roche,
Indianapolis, IN, USA). After intraperitoneal injection, further blood
samples were taken at 15, 30, 60 and 120 min post-injection. Area under the
curve (AUC) was calculated using GraphPad Prism.
Mice were individually housed for 48 h in indirect calorimetry cages
(LabMaster system; TSE-systems, Bad Homburg, Germany) at 24 weeks of
age. A final blood glucose reading was collected from 26-week-old mice
after a 4 h fast, followed by anaesthesia (100 mg kg−1 ketamine and
10 mg kg−1 xylazine) and culling, with retro-orbital blood and multiple
tissue samples collected.
Ex vivo analysis
Heparinized whole-blood samples were centrifuged at 5000 g for 10 min at
4°C, and the separated plasma was analysed using an Olympus AU400
(Olympus, Tokyo, Japan). Insulin concentrations were determined by
ELISA, according to the manufacturer’s instructions (Millipore, Billerica,
MA, USA).
Table 2. Differentially regulated genes identified by DESeq2 analysis of RNAseq data (differentially expressed genes filtered using Padj<0.05)
Organ Gene name Ensembl ID Lfc P-value Padj
Gastrocnemius Lyplal1 ENSMUSG00000039246 −0.6533 1.71×10−33 5.65×10−29
Liver Lyplal1 ENSMUSG00000039246 −4.0807 P<1×10−200 P<1×10−200
Nuak1 ENSMUSG00000020032 −0.2667 2.98×10−6 0.0491
scWAT Lyplal1 ENSMUSG00000039246 −5.7517 2.13×10−150 7.68×10−146
Entpd1 ENSMUSG00000048120 −0.3180 3.28×10−12 5.92×10−8
Sdc1 ENSMUSG00000020592 −0.7262 4.50×10−11 5.41×10−7
S1pr2 ENSMUSG00000043895 −0.4830 4.66×10−6 0.0420
vWAT Lyplal1 ENSMUSG00000039246 −4.0325 1.04×10−188 2.60×10−184
Myom2 ENSMUSG00000031461 −0.5878 2.67×10−7 0.0033
Ddn ENSMUSG00000059213 −0.6754 4.03×10−7 0.0034
Tmem151a ENSMUSG00000061451 0.6345 6.98×10−6 0.0438
Cmya5 ENSMUSG00000047419 −0.6369 9.73×10−6 0.0467
Hfe2 ENSMUSG00000038403 −0.5217 1.41×10−5 0.0467
Hrc ENSMUSG00000038239 −0.5130 1.86×10−5 0.0467
Myoz1 ENSMUSG00000068697 −0.4504 1.66×10−5 0.0467
Brd2 ENSMUSG00000024335 −0.1277 1.63×10−5 0.0467
Gm5578 ENSMUSG00000029633 0.2073 1.70×10−5 0.0467
Klhl41 ENSMUSG00000075301 −0.4958 2.22×10−5 0.0472
Tcap ENSMUSG00000007877 −0.4259 2.26×10−5 0.0472
lfc, log2 fold change; scWAT, subcutaneous white adipose tissue; vWAT, visceral white adipose tissue.
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Protein extracts were generated from frozen tissue samples by
homogenization in tissue protein extraction reagent (TPER) buffer
supplemented with Halt protease and phosphatase inhibitor cocktail (both
from Thermo Scientific, Rockfold, IL, USA), using an Omni TH Tissue
homogenizer (Omni International, NW Kennesaw, GA, USA). Western
blotting of tissue protein extracts was performed using standard protocols,
using the blocking solutions (in TBS with 0.1% Tween 20) and the
following antibodies: rabbit anti-Lyplal1 (Proteintech Group, Rosemont, IL,
USA; 1:1000), mouse anti-GAPDH (Abcam, Cambridge, UK; 1:5000),
goat anti-rabbit (Bio-Rad, Hercules, CA, USA; 1:10,000) or goat anti-
mouse (Bio-Rad; 1:10,000). The blocking solutions were 3% [w/v] milk
(for rabbit anti-Lyplal1 and goat anti-rabbit) or 3% [w/v] BSA (for mouse
anti-GAPDH and goat anti-mouse). The blots were visualized using
Amersham ECL reagents (GE Healthcare, Chicago, IL, USA) and
developed using a Xograph Imaging Systems Compact X4.
Paraffin sections (5 µm thickness) of scWAT were stained with
Haematoxylin and Eosin (H&E) using a Leica ST5020 Multistainer
machine and a Leica CV5030 Cover Slipper (Leica, Wetzlar, Germany).
Cryosections (10 µm thick) of liver were stained with H&E or Oil Red O and
Haematoxylin by conventional methods. Images were collected using a
Leica stereomicroscope and a Hamamatsu slide scanner (Hamamatsu,
Japan). Adipocyte CSA analysis was calculated from one section of 1.8 mm
×1.34 mm per mouse using ImageJ software (NIH).
RNA extraction and qPCR
RNAwas extracted from snap-frozen mouse tissue using the Qiagen RNeasy
plus Universal kit according to the manufacturer’s instructions (Qiagen,
Hilden, Germany). RNA concentration and purity were evaluated by
NanoDrop (Thermo Scientific, Wilmington, DE, USA). RNA integrity was
further assessed using an Agilent Bioanalyzer (Agilent Technologies, Santa
Clara, CA, USA). cDNA synthesis was performed using between 500 ng and
1 µg RNA, random primers and Superscript II reverse transcriptase (Life
Technologies, Carlsbad, CA, USA). qPCR was performed using Sybr Green
(Applied Biosystems, Foster City, CA, USA) and run on an AB7500 qPCR
machine (Applied Biosystems). The following primers were used: for 18S,
forward 5′-GTAACCCGTTGAACCCCATT-3′ and reverse 5′-CCATCCA-
ATCGGTAGTAGCG-3′; Gapdh, forward 5′-TGGTTCACACCCATCACA-
AACA-3′ and reverse 5′-GGTGAAGGTCGGTGTGAACGG-3′; for
Lyplal1, forward 5′-CACGGCTCAGGTCACTCTGG-3′ and reverse 5′-A-
GGGGGCCGTTGGATAAATG-3′; for Rpl32, forward 5′-GGCCAGATC-
CTGATGCCCAAC-3′ and reverse 5′-CAGCTGTGCTGCTCTTTCTAC-3′.
Relative expression forLyplal1was calculated using theΔΔCtmethod, relative
to the cubic mean of three reference genes (Livak and Schmittgen, 2001).
RNAseq
RNAseq was performed on five samples per sex and genotype from
gastrocnemius, liver, scWAT and vWAT. Libraries were prepared using the
Illumina TruSeq StrandedmRNALibrary PreparationKit with 10 PCRcycles
(Illumina, San Diego, CA, USA). Pools of 20 samples (one pool per organ)
were run on three lanes each with 75-bp paired end runs on an Illumina Hiseq
2000with v4 chemistry, with each pool run on three lanes. Readswere aligned
to the NCBI m38 version of the mouse genome, data from multiple lanes
combined using Samtools v1.3, mapped reads counted using Feature Counts
with duplicates retained and differential expression analysed using DESeq2
(Love et al., 2014). Outliers that did not cluster with the appropriate tissue on
the principal components analysis plot were removed. The data were
visualized using Integrative Genomics Viewer to confirm the location of any
remaining reads in knockout samples (Robinson et al., 2011). RNAseq data
are available through the European Nucleotide Archive (ENA), study number
PRJEB14194 (https://www.ebi.ac.uk/ena/data/view/PRJEB14194).
Statistical analysis
Unless otherwise stated, statistical analysiswas performed as describedbyKarp
et al. (2012), using PhenStat version 2.3.2, using the mixed model framework
(Kurbatova et al., 2015). Multiple testing was managed by controlling the
family-wise error rate to 5% using the Holm method (Holm, 1979).
YDietþ Sexþ Diet Sexþ ð1jBatchÞ ð1Þ
For indirect calorimetry, data analysis was performed in R, using linear model
analysis, and correcting for body weight when assessing energy expenditure,
O2 uptake and CO2 output, and correcting for change in body weight when
assessing food intake and respiratory exchange ratio. Interaction terms were
checked and were not significant; therefore, these were excluded from the
model.
Model , lm(Variable1þ Genotypeþ SexþWeightþ BatchÞ ð2Þ
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